Norges Bank
RCKT icon

Norges Bank’s Rocket Pharmaceuticals RCKT Stock Holding History

Norges Bank’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-44,294
Closed -$295K – 1757
2025
Q1 		$295K Buy
+44,294
New +$438K ﹤0.01% 1716
2024
Q4 		– Sell
-159,094
Closed -$2.94M – 1892
2024
Q3 		$2.94M Buy
159,094
+124,342
+358% +$2.55M ﹤0.01% 1607
2024
Q2 		$748K Sell
34,752
-26,099
-43% -$599K ﹤0.01% 1845
2024
Q1 		$1.64M Sell
60,851
-182,500
-75% -$5.18M ﹤0.01% 1755
2023
Q4 		$7.29M Hold
243,351
– – ﹤0.01% 1585
2023
Q3 		$4.99M Hold
243,351
– – ﹤0.01% 1674
2023
Q2 		$4.84M Hold
243,351
– – ﹤0.01% 1727
2023
Q1 		$4.17M Sell
243,351
-77,422
-24% -$1.52M ﹤0.01% 1807
2022
Q4 		$6.28M Hold
320,773
– – ﹤0.01% 1711
2022
Q3 		$5.12M Hold
320,773
– – ﹤0.01% 1757
2022
Q2 		$4.41M Sell
320,773
-7,800
-2% -$93K ﹤0.01% 1796
2022
Q1 		$5.21M Sell
328,573
-154,206
-32% -$2.66M ﹤0.01% 1859
2021
Q4 		$10.5M Buy
482,779
+151,100
+46% +$4.12M ﹤0.01% 1743
2021
Q3 		$9.91M Sell
331,679
-9,633
-3% -$351K ﹤0.01% 1771
2021
Q2 		$15.1M Buy
341,312
+13,302
+4% +$578K ﹤0.01% 1648
2021
Q1 		$14.6M Buy
328,010
+303,010
+1,212% +$16.6M ﹤0.01% 1664
2020
Q4 		$1.37M Buy
+25,000
New +$911K ﹤0.01% 1994

Other funds holding RCKT

RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Maverick Capital
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

Norges Bank's RCKT Position: Q2 2025 in Review

Norges Bank sold out of Rocket Pharmaceuticals (RCKT) in Q2 2025, closing a stake of 44,294 shares — an estimated $295K sold.

Norges Bank first reported a position in RCKT in Q4 2020 and held it in 17 quarters. The position peaked at $15.1M in Q2 2021. 196 funds tracked by Wall St. Rank hold RCKT as of Q2 2025.

  • Norges Bank reported no remaining Rocket Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Norges Bank sold 44,294 Rocket Pharmaceuticals shares in Q2 2025, an estimated $295K.
  • Norges Bank first reported a position in Rocket Pharmaceuticals in Q4 2020 and held it in 17 quarters.
  • Norges Bank's Rocket Pharmaceuticals position peaked at $15.1M in Q2 2021.
  • 196 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2025.

Based on Norges Bank's 13F filing for Q2 2025, filed 13 Aug 2025.